Literature DB >> 9291308

Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.

R M Selik1, J M Karon, J W Ward.   

Abstract

To measure the effect of the human immunodeficiency virus (HIV) epidemic on mortality from opportunistic infections (OIs) in 1993, national multiple-cause death certificate data were examined using two approaches. First, for each OI, the percentage of deaths with HIV infection reported as the underlying cause was calculated. Second, the age-adjusted rate of death per million population was compared with the rate predicted from a model of rates in 1970-1980 or 1979-1981, as available. The percentage of deaths with HIV as the underlying cause and the ratio of observed to predicted death rates were as follows: toxoplasmosis, 91% and 86 (5.24/0.06); cryptosporidiosis/isosporiasis, 90% and infinite (1.61/0.00); progressive multifocal leukoencephalopathy, 87% and 19 (2.58/0.13); pneumocystosis, 82% and 18 (15.44/0.87); cytomegalovirus disease, 82% and 17 (12.60/0.74); nontuberculous mycobacteriosis, 79% and 18 (15.51/0.84); cryptococcosis, 76% and 4 (5.80/1.35); and histoplasmosis, 68% and 6 (1.36/0.23). Thus, the HIV epidemic has greatly increased mortality from several OIs.

Entities:  

Mesh:

Year:  1997        PMID: 9291308     DOI: 10.1086/514083

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Life and death in a macrophage: role of the glyoxylate cycle in virulence.

Authors:  Michael C Lorenz; Gerald R Fink
Journal:  Eukaryot Cell       Date:  2002-10

Review 2.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

4.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

5.  Organ transplantation in HIV-infected individuals: The time has come - should there be criteria?

Authors:  Sharon Walmsley
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-01       Impact factor: 2.471

Review 6.  Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.

Authors:  Fariha Zaheer; Joseph R Berger
Journal:  Ther Adv Drug Saf       Date:  2012-10

7.  Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice.

Authors:  G Abenes; M Lee; E Haghjoo; T Tong; X Zhan; F Liu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  The changing landscape of progressive multifocal leukoencephalopathy.

Authors:  Sachin Kedar; Joseph R Berger
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

9.  Evolution of Cryptococcal Antigen Testing: What is new?

Authors:  Elizabeth Nalintya; Reuben Kiggundu; David Meya
Journal:  Curr Fungal Infect Rep       Date:  2016-04-12

10.  Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infections.

Authors:  J Jason; L Archibald; L C McDonald; W M Hart; S Rheanppumikankit; S Tansuphwaswadikul; M G Byrd; J Larned; A Han; T A Green; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.